fbpx A partnering event for biotechnologies | Page 20 | Science in the net

A partnering event for biotechnologies

Read time: 1 min

The Enterprise Europe Network, of which the University of Roma Tor Vergata is a member, organizes EEN Biotech and Bioeconomy Partnering  Event – IFIB  2013 (Naples, October 22nd-23rd 2013).

The international event is part of the workshop Italian Forum on  Industrial Biotechnology and Bioeconomy  (IFIB) 2013, organized by  Assobiotec (Italian Association for the development of biotechnologies), in collaboration with Innovhub – SSI, Italian Biocatalysis Center and the Chamber of Commerce, Industry, Craftmanship and Agricolture of Naples. 

  • IFIB 2013 aims to identify research projects in the field of industrial biotechnology in order to strengthen the Euro-Mediterranean network and the industry-university partnerships (for information: www.assobiotec.federchimica.it).
  • EEN Biotech and Bioeconomy Partnering  Event will encourage the dialogue between potential partners during predetermined individual meetings, with the aim of fostering new collaboration opportunities in range of commerce, technology transfer and research (for information: http://www.parcoscientifico.eu/node/541, for registration: http://www.b2match.eu/ifib2013).

Fields of interests: Industrial biotechnologies, including biocatalysts; environmental technologies; energy and biofuels; pharmaceutics; chemicals; food farming; marine biotechnologies. 

Both the events are free of charge. For any information, send a mail to: [email protected]

Autori: 
Sezioni: 
Biotechnology

prossimo articolo

We cannot archive Covid-19 yet

Coexistence with Covid-19 cannot yet be said to be stable, especially due to the great variability of SARS-CoV-2. For this reason, as the number of cases in Italy is increasing, it is necessary to limit the impact of infections by acting on two fronts, which are not alternatives to each other: reduce the share of people who have become partially susceptible and limit the likelihood of the emergence of new variants.

Image credits: Prasesh Shiwakoti (Lomash)/Unsplash

Several attempts have been made to archive Covid-19, trying to leave behind an experience worthy of the worst dystopian novel (about 770 million officially registered cases worldwide and an estimated 18 million deaths), but it seems that the anticipated "coexistence" with the family of viruses has not yet stabilized, and it will take several years to get there.